Norimoto Hisayoshi
Amministratore Delegato presso PuraPharm Japan Corp.
Patrimonio netto: 35 069 $ in data 30/06/2024
Profilo
Norimoto Hisayoshi is currently the Chief Executive Officer at PuraPharm Japan Corp.
and also holds a position as General Manager at Sodx Co., Ltd.
His former positions include Executive Director at PuraPharm Corp.
Ltd., Head of Research & Development at Kracie Pharma Ltd.
and Kracie Pharmaceutical Ltd., Chief Research & Development Officer & GM at PuraPharm Corp.
Ltd., and General Manager at PuraPharm Japan Corp.
His education includes a doctorate and graduate degree from the University of Toyama.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
PURAPHARM CORP. LTD.
0.09% | 31/12/2022 | 370 000 ( 0.09% ) | 35 069 $ | 30/06/2024 |
Posizioni attive di Norimoto Hisayoshi
| Società | Posizione | Inizio |
|---|---|---|
Sodx Co., Ltd.
 Sodx Co., Ltd. Food RetailRetail Trade Part of PuraPharm Corp. Ltd., Sodx Co., Ltd. is a Japanese real estate company that specializes in condominium management and asset management. The company promises a safe and rich future that does not rely on public pensions through valuable real estate. The company aims to provide attractive condominiums with high asset value to realize a relaxed life. Sodx Co. was acquired by PuraPharm Corp. Ltd. on August 28, 2017 for $2.24 million. | Corporate Officer/Principal | - |
| PuraPharm Japan Corp. | Amministratore Delegato | 20/11/2023 |
Precedenti posizioni note di Norimoto Hisayoshi
| Società | Posizione | Fine |
|---|---|---|
| PURAPHARM CORPORATION LIMITED | Direttore/Membro del Consiglio | 20/11/2023 |
| Kracie Pharmaceutical Ltd. | Direttore Tecnico/Scientifico/R&S | 01/01/2016 |
Kracie Pharma Ltd.
 Kracie Pharma Ltd. Pharmaceuticals: MajorHealth Technology Kracie Pharma Ltd. engages in the research and development of pharmaceutical products. It specializes in the manufacture and sale of kampo medicines and other related medicines for hospitals. The company was founded on May 1, 2006 and is headquartered in Tokyo, Japan. | Direttore Tecnico/Scientifico/R&S | 01/01/2006 |
| PuraPharm Japan Corp. | Corporate Officer/Principal | - |
| PURAPHARM CORPORATION LIMITED | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Norimoto Hisayoshi
| University of Toyama | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PURAPHARM CORPORATION LIMITED | Health Technology |
| Aziende private | 4 |
|---|---|
Kracie Pharma Ltd.
Kracie Pharma Ltd. Pharmaceuticals: MajorHealth Technology Kracie Pharma Ltd. engages in the research and development of pharmaceutical products. It specializes in the manufacture and sale of kampo medicines and other related medicines for hospitals. The company was founded on May 1, 2006 and is headquartered in Tokyo, Japan. | Health Technology |
| Kracie Pharmaceutical Ltd. | |
Sodx Co., Ltd.
Sodx Co., Ltd. Food RetailRetail Trade Part of PuraPharm Corp. Ltd., Sodx Co., Ltd. is a Japanese real estate company that specializes in condominium management and asset management. The company promises a safe and rich future that does not rely on public pensions through valuable real estate. The company aims to provide attractive condominiums with high asset value to realize a relaxed life. Sodx Co. was acquired by PuraPharm Corp. Ltd. on August 28, 2017 for $2.24 million. | Retail Trade |
| PuraPharm Japan Corp. |
- Borsa valori
- Insiders
- Norimoto Hisayoshi
